1) Phenytoin/blood
苯妥英/血液
2) fosphenytoin
磷苯妥英
1.
A new method for the preparation of fosphenytoin was discussed in this paper.
以抗癫痫药物苯妥英为原料,通过合成3-羟甲基-苯妥英、3-氯甲基-苯妥英、3-羟甲基-苯妥英磷酸二苄酯、3-羟甲基-苯妥英磷酸酯等4种中间产物,最终得到目标产物磷苯妥英,总收率35。
2.
OBJECTIVE To develop a simple reversed-phase high-performance liquid chromatography(HPLC) method for thesimultaneous determination of the antiepileptic drugs(AEDs) phenytoin(PHT),its prodrug fosphenytoin(FOS),and its metabolite 4′-hydroxyphenytoin(4′-HPPH) in human plasma.
目的建立同时测定人血浆中抗癫痫药物磷苯妥英(FOS)、苯妥英(PHT)及其主要代谢产物4′-羟苯妥英(4′-HPPH)浓度的高效液相色谱法。
3) phenytoin sodium
苯妥英钠
1.
Determination of phenytoin sodium and schisandrin in Compound Valpromide Capsule by HPLC;
HPLC测定复方丙戊酰胺胶囊中苯妥英钠和五味子醇甲的含量
2.
Pharmaceutical care of severe toxicosis of phenytoin sodium;
重度苯妥英钠中毒的药学监护
4) Phenytoin
[英]['fenitɔin] [美][,fɛnɪ'toɪn, fə'nɪto-]
苯妥英
1.
Damage of Ileum in Experimental Peritonitis in mice and Effect of Phenytoin Sodium Intervention;
小鼠实验性腹膜炎回肠组织损伤性变化以及苯妥英钠干预的影响
2.
Simultaneous determination of phenobarbitone,phenytoin and carbamazepine in human plasma by RP-HPLC;
RP-HPLC同时测定苯巴比妥、苯妥英和卡马西平的血药浓度(英文)
3.
Simultaneous separation and determination of zonisamide,phenytoin carbamazepine and carbamazepine 10,11-epoxide in human plasma using isocratic reversed-phase HPLC;
高效液相色谱法同时测定人血浆中唑尼沙胺、苯妥英、卡马西平及环氧卡马西平的浓度
5) sodium phenytoin
苯妥英钠
1.
Association of plasma sodium phenytoin concentration with CYP2C19 gene polymorphism;
苯妥英钠血药浓度与CYP2C19基因多态性关系的研究
2.
A method to determine sodium phenytoin in plasma by high performance capillary zone electrophoresis(CZE) has been established.
建立了以毛细管区带电泳测定血浆中苯妥英钠含量的方法。
3.
Objective: To investigate the effects of sodium phenytoin poly (lactide-co-glycolide) microspheres Poloxamer 407 gel (PHT-PLGA-MG) on periodontal wound healing in fenestration defects of rats, and provide an in vivo basis for the development of new PHT formulation for local drug delivery.
目的:探讨苯妥英钠聚乳酸-羟基乙酸微球泊洛沙姆407凝胶(sodiumphenytoin poly(lactide-co-glycolide)microspheres poloxamer 407 gel,PHT-PLGA-MG)对大鼠下颌磨牙区颊侧牙周骨开窗缺损牙周再生的影响,为开发苯妥英钠局部用药新剂型提供体内动物实验的依据。
6) dilantin
[英][dai'læntin] [美][daɪ'læntɪn]
苯妥英钠
1.
Determination of dilantin and its content in tablets by means of Gran graphics;
Gran图解法测定苯妥英钠及其片剂的含量
2.
Influence of Dilantin on serum immunosuppressive factor in burn patients;
苯妥英钠对烧伤患者血清免疫抑制因子的影响
3.
Objectives:To explore the neuroelectropysiological features of patients with epilepsy in long-term taking dilantin.
目的:观察长期服用苯妥英钠的癫患者周围神经损害。
补充资料：苯异妥英
分子式：C9H8N2O2
分子量：176.17
CAS号：2152-34-3
性质：白色结晶性粉末。熔点256-257℃（分解）。难溶于水、醚、丙酮和稀盐酸。无臭无味。
制备方法：由苯甲醛经与氯仿缩合、水解得到α-羟基苯乙酸，再经酯化、环合而得匹莫林。
用途：该品为中枢神经兴奋药，兴奋作用中咖啡因的20倍，用于治疗脑功能失调症，轻型优郁症及发作性睡病等。但不良反应较多，逐渐被三环及四环类抗忧郁药所替代。大鼠口服LD50为500mg/kg。
分子量：176.17
CAS号：2152-34-3
性质：白色结晶性粉末。熔点256-257℃（分解）。难溶于水、醚、丙酮和稀盐酸。无臭无味。
制备方法：由苯甲醛经与氯仿缩合、水解得到α-羟基苯乙酸，再经酯化、环合而得匹莫林。
用途：该品为中枢神经兴奋药，兴奋作用中咖啡因的20倍，用于治疗脑功能失调症，轻型优郁症及发作性睡病等。但不良反应较多，逐渐被三环及四环类抗忧郁药所替代。大鼠口服LD50为500mg/kg。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条